Menu Search
Equities

Pasture Holdings Ltd

UUK:SES

Pasture Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SGD)0.049
  • Today's Change0.001 / 2.08%
  • Shares traded10.00k
  • 1 Year change-73.51%
  • Beta--
Data delayed at least 10 minutes, as of Nov 15 2024 02:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Pasture Holdings Ltd grew revenues 44.92% from 9.70m to 14.06m. In addition the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as a percent of sales). The company reported positive net income, improving from a loss of 1.30m to a profit of 559.00k.
Gross margin24.65%
Net profit margin3.97%
Operating margin5.18%
Return on assets5.55%
Return on equity13.61%
Return on investment11.26%
More ▼

Cash flow in USDView more

In 2024, Pasture Holdings Ltd increased its cash reserves by 9.39%, or 394.00k. The company earned 817.00k from its operations for a Cash Flow Margin of 5.81%. In addition the company used 237.00k on investing activities and also paid 186.00k in financing cash flows.
Cash flow per share0.0087
Price/Cash flow per share5.62
Book value per share0.0447
Tangible book value per share0.0447
More ▼

Balance sheet in USDView more

Pasture Holdings Ltd has a Debt to Total Capital ratio of 32.02%, a higher figure than the previous year's 1.41%.
Current ratio1.60
Quick ratio1.00
Total debt/total equity0.4709
Total debt/total capital0.3202
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 136.88%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		137.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.